JTCS Tips for Better Browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Heikki Sairanen
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pesonen, E. J.
Right arrow Articles by Andersson, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pesonen, E. J.
Right arrow Articles by Andersson, S.

J Thorac Cardiovasc Surg 1995;110:768-0773
© 1995 Mosby, Inc.


CARDIOPULMONARY BYPASS,
MYOCARDIAL MANAGEMENT, AND SUPPORT TECHNIQUES

Regional generation of free oxygen radicals during cardiopulmonary bypass in children

Eero J. Pesonen, MDa, Reijo Korpela, MDa, Kaija Peltola, MDa, Mauri Leijala, MDa, Heikki Sairanen, MDa, Kari O. Raivio, MDa, Per Venge, MDb, Sture Andersson, MDac

Helsinki, Finland, and Uppsala, Sweden

Supported by the Foundation for Pediatric Research, Academy of Finland,and the Sigrid Jusélius Foundation.

Received for publication Oct. 27, 1994. Accepted for publication Feb. 13, 1995. Address for reprints: Eero J. Personen, MD, Children's Hospital, Stenbackinkatu 11, 00290 Helsinki, Finland.

Abstract

Studies on free radical generation during cardiopulmonary bypass have focused mainly on the heart and the lungs. However, low pumping pressure, nonpulsatile perfusion, and hypothermia affect the entire circulation, resulting in decreased splanchnic blood flow, increased intestinal permeability, and endotoxemia. To evaluate regional phenomena, we studied 16 children undergoing cardiopulmonary bypass. Free radical production, granulocyte activation, and hypoxanthine metabolism were assessed separately in the circulations drained by the inferior and superior venae cavae, as well as in the oxygenator. Three minutes after the onset of cardiopulmonary bypass, significant gradients between the inferior vena cava and the arterial line of the oxygenator existed in malondialdehyde (+0.60±0.12µmol/L, lactoferrin (+18.21±7.65µg/L), myeloperoxidase (+53.75±16.50µg/L), hypoxanthine (-0.62±0.15µmol/L), and urate (+8.87±4.03µmol/L). These gradients decreased in parallel with decreasing body temperature. Except for a transient gradient in malondialdehyde at 3 minutes after the onset of cardiopulmonary bypass (+0.23±0.08µmol/L), no changes were detected between the superior vena cava and the arterial line. In the oxygenator, granulocyte activation was observed only after aortic declamping. We conclude that during cardiopulmonary bypass, significant free radical generation, granulocyte activation, hypoxanthine elimination, and urate production take place in the region drained by the inferior vena cava. In the oxygenator, granulocyte activation occurs only after aortic declamping. (J THORACCARDIOVASCSURG1995;110: 768-73)

Increased free radical activity during cardiopulmonary bypass (CPB) has been associated with myocardial and pulmonary dysfunction.Go 1 CPB activates the complement system, which leads to granulocyte activation and free radical production.Go 2 During ischemia, the enzyme xanthine dehydrogenase is converted to xanthine oxidase, in which form it generates free radicals as by-products during metabolism of hypoxanthine and xanthine to urate.Go 3

Interest in free radical activity during cardiac operations has focused on the heart and the lungs, because they are exposed to ischemia and subsequent reperfusion during CPB. However, low pumping pressure, nonpulsatile perfusion, and hypothermia cause considerable hemodynamic changes in the entire circulation. During hypothermic perfusion in animal models, cerebral, renal, and splanchnic flows diminish and femoral artery flow increases.Go 4 Recent studies in human beings show a 46% reduction in gastric mucosal blood flow during CPB.Go 5 Splanchnic hypoperfusion may cause increased intestinal permeability and endotoxemia.Go Go 5,6 If free radicals play a role in these changes, increased free radical activity may be measurable in venous return from the splanchnic region.

This study was conducted to evaluate regional changes in free radical activity and its two potential sources, granulocyte activation and xanthine metabolism, during CPB in children.

METHODS

Patients
We studied 16 children undergoing CPB for elective repair of congenital heart defects Go(Table I). All the patients were in stable condition during the induction and preinduction phases.


View this table:
[in this window]
[in a new window]
 
Table I. Patient data
 
Anesthesia and operation
Patients were premedicated with flunitrazepam (0.1 mg/10 kg p.o.). Anesthesia was induced with fentanyl, thiopentone sodium or ketamine, and pancuronium and maintained with a high dose of fentanyl (50–100 µg/kg). Isoflurane was administered if needed. CPB was established with the use of a Masterflo 34 (<15 kg) or a Masterflo 51 (>15 kg) pediatric hollow-fiber membrane oxygenator and a Midicard 20µ cardiotomy reservoir (Dideco S.p.A., Mirandola, Italy). A roller pump (Gambro, Lund, Sweden) was used with a standard flow of 2.4 L/min per square meter (at 37° C), which was then reduced to match the requirements according to the degree of hypothermia. Circulatory arrest was used in one patient; postarrest values for this patient were excluded. Barbiturates or steroids to protect the brain were not given.

A prime solution comprising albumin and fresh whole blood was used to adjust the hematocrit value to 25%. During rewarming, hemofiltration (Ultraflux 400 filter, Fresenius, Germany) was used consistently and uniformly to increase the hematocrit value to at least 30%. To achieve this, we added fresh whole blood, if needed. Mannitol (15%) was administered as an infusion of 1 ml/kg per hour from the beginning of the perfusion. The protein inhibitor aprotinin (30,000 IU/kg) was added in the priming solution, and the same amount also was infused for 1 hour after the induction of anesthesia. Infusion of aprotinin (8000 IU/kg per hour) was continued throughout CPB. For myocardial preservation, cold (+4° C) blood cardioplegic solution (30 ml/kg) was used initially and repeated (10 ml/kg) every 20 minutes. On the decision of the surgeon, the last cardioplegic solution (300 ml/m2), containing 2 mmol/100 ml aspartate and 2 mmol/100ml glutamate ("hot shot"), was infused immediately before aortic declamping. None of the patients received allopurinol. Whole body temperature was assessed by measuring mixed venous temperature.

Sample collection
Blood samples were collected after induction of anesthesia but before the operation began; at 3, 20, and 40 minutes after the onset of CPB; and at 2, 7, and 12 minutes after aortic declamping. Blood samples were obtained simultaneously from radial arterial and central venous catheters before CPB and from the superior (SVC) and inferior (IVC) venae cavae and from the arterial and venous lines (mixed venous value) of the oxygenator during CPB. Samples specifically from the IVC were obtained by means of a side line on the IVC cannula, and samples from the SVC were obtained through a central venous catheter, the tip of which was placed in the SVC. The CPB cannulation and snaring of the vessel proximally prevented blood in the SVC from mixing with blood from the IVC. The samples collected in tubes containing ethylenediaminetetraacetic acid were immediately centrifuged for 5 minutes at 1000 g. An aliquot of 150 µl of plasma for malondialdehyde measurement was immediately added to 15 µl of deferoxamine 100 mg/ml (Desferal, Ciba-Geigy, Basel, Switzerland). The samples were stored at -70° C.

Assays
Hypoxanthine was quantified with high-pressure liquid chromatography, urate by a Hitachi 705E device (Hitache Ltd., Tokyo, Japan) by an enzymatic method, lactoferrin and myeloperoxidase by radioimmunology, and malondialdehyde by measurement of thiobarbituric acid–reactive material.Go Go 7-10

Statistical analysis
Plasma concentrations were calculated both corrected and uncorrected for hematocrit value. Within CPB, hemodilution did not have a significant effect on results. Therefore results during CPB are presented only uncorrected. Pre-CPB values are given both uncorrected and corrected to correspond with the hemodilution of the first sample during CPB. In statistical analysis, the two-tailed Wilcoxon test and analysis of variance (ANOVA) were used. A p value less than 0.05 was considered significant. Patient data are presented as median and range. Results are presented either as individual values or as mean ± standard error of the mean.

Ethics
The study was approved by the ethics committee of the Children's Hospital, University of Helsinki, and informed consent was obtained from the parents.

RESULTS

Malondialdehyde
After the onset of CPB, there was an apparent decrease in mixed venous malondialdehyde concentration compared with preoperative values, but after correction for hemodilution during CPB, this difference disappeared (Fig. 1, A). At 3 minutes after the onset of CPB, malondialdehyde concentration was higher in the SVC than in the arterial line of the oxygenator Go(Table II). At 3 and 20 minutes after the onset of CPB, malondialdehyde concentration was higher in the IVC than in the arterial line of the oxygenator (GoTable II and Fig. 2, B). This difference diminished gradually with decreasing body temperature (Fig. 2, B). No differences could be detected between the arterial and venous lines of the oxygenator.







View larger version (141K):
[in this window]
[in a new window]
 
Fig. 1. Mixed venous concentrations of malondialdehyde (MDA), hypoxanthine (HX), urate (UR), lactoferrin (LF), and myeloperoxidase (MPO). Preoperative values corrected for hemodilution during CPB are depicted with dots. {dagger}p < 0.05, {dagger}{dagger}p < 0.01, and {dagger}{dagger}{dagger}p < 0.001 versus 0 minutes; *p < 0.05 and **p < 0.01 versus 40 minutes aaaafter the onset of CPB (Wilcoxon test).

 

View this table:
[in this window]
[in a new window]
 
Table II. Differences in parameters between IVC or SVC and the arterial line of the oxygenator (A)
 






View larger version (75K):
[in this window]
[in a new window]
 
Fig. 2. Mixed venous temperature (V-TEMP) and differences in plasma concentrations of malondialdehyde (MDA), hypoxanthine (HX), urate (UR), lactoferrin (LF), and myeloperoxidase (MPO) between the IVC and the arterial line of the oxygenator. {dagger}p < 0.05, {dagger}{dagger}p < 0.01, for IVC versus A (Wilcoxon test).

 
Hypoxanthine
At 3 minutes after the onset of CPB, mixed venous hypoxanthine concentration was already increased, and it became elevated further after aortic declamping (Fig. 1, B). During the entire period of CPB, there were no differences in hypoxanthine concentration between the SVC and the arterial line of the oxygenator nor between the arterial and venous lines of the oxygenator Go(Table II). At 3 minutes after the onset of CPB, hypoxanthine concentration was significantly lower in the IVC than in the arterial line of the oxygenator (GoTable II and Fig. 2, C). Significant differences in the same direction were also observed 2, 7, and 12 minutes after aortic declamping ( p = 0.0174, p = 0.0022, and p = 0.0024, respectively).

Urate
Compared with preoperative values, the mixed venous concentration of urate decreased during CPB, but not if corrected for hemodilution (Fig. 1, C). No differences in urate concentration were observed between the SVC and the arterial line of the oxygenator, nor between the arterial and venous lines of the oxygenator (see GoTable II). Urate content was higher in the IVC than in the arterial line of the oxygenator at 3 and 20 minutes after the onset of CPB (GoTable II and Fig. 2, C) and at 2 minutes after aortic declamping ( p = 0.0025).

Lactoferrin and myeloperoxidase
Mixed venous concentrations of both lactoferrin and myeloperoxidase increased significantly during CPB (Fig. 1, D and E). Further increase of lactoferrin concentration occurred after aortic declamping (Fig. 1, D). No differences in lactoferrin or myeloperoxidase concentration were observed between the SVC and the arterial line of the oxygenator Go(Table II). At 3 minutes after the onset of CPB, both lactoferrin and myeloperoxidase were higher in the IVC than in the arterial line of the oxygenator (GoTable II and Fig. 2, D and E). This difference diminished gradually with decreasing body temperature (Fig. 2, D and E). Both lactoferrin and myeloperoxidase concentrations were higher in the arterial than in the venous line of the oxygenator after aortic declamping, but not during crossclamping (Fig. 3).



View larger version (38K):
[in this window]
[in a new window]
 
Fig. 3. Plasma lactoferrin (LF) and myeloperoxidase (MPO) concentration differences between arterial and venous lines of the oxygenator. {dagger}p < 0.05 and {dagger}{dagger}p < 0.01 for arterial versus venous line (Wilcoxon test).

 
DISCUSSION

This study demonstrates increased granulocyte activation, hypoxanthine metabolism, and free radical generation during CPB in the circulation drained by the IVC. The magnitudes of these phenomena decrease in parallel with decreasing body temperature.

We did not detect any increase in lipid peroxidation, measured as malondialdehyde concentration, during the entire CPB period. This is consistent with a recent study.Go 11 Increased malondialdehyde production after aortic declamping has been demonstrated in blood samples obtained from the left atrium, that is, in blood drained specifically from the pulmonary circulation.Go 12 Those results may not be compared with the mixed venous concentrations measured in this study. Although no systemic increase in malondialdehyde was detected in this study, a transient increase was found at the start of CPB in both the SVC and the IVC.

We found a very rapid increase in hypoxanthine as early as 3 minutes after the onset of CPB. The most probable explanation is cellular hypoxia caused by hypoperfusion.Go 13 Despite seemingly adequate central hemodynamics and oxygenation during cardiac operations, peripheral tissue perfusion is restricted, as suggested by an increase in arterial concentration of lactate after the onset of CPB.Go 14 During reperfusion after aortic declamping, we observed a further increase in hypoxanthine, probably reflecting washout of hypoxanthine accumulated in ischemic myocardial and pulmonary tissues. The finding is in accordance with earlier observations of hypoxanthine liberation after transient cardiac ischemia, during reperfusion in cardiac operations, and during heart-lung transplantation.Go Go 15-17

Xanthine oxidase/dehydrogenase activities vary between organs. In this study, at 3 minutes after the onset of CPB and at 2 minutes after aortic declamping, hypoxanthine decreased and urate increased in the IVC but not in the SVC. This result is compatible with high xanthine oxidase/dehydrogenase activity in splanchnic organs but low or no activity in skeletal muscle and brain.Go Go 18,19

CPB leads to rapid intravascular granulocyte activation, presumably caused by complement activation through the alternative pathway when plasma contacts the unphysiologic surfaces of the oxygenator.Go Go 2,20 However, granulocytic degranulation, indicative of granulocyte activation, has not previously been measured in the oxygenator. We found a rapid increase in lactoferrin and myeloperoxidase concentrations from the beginning of CPB. At the beginning of CPB, degranulation was localized not to the oxygenator but to the circulation drained by the IVC. Only after aortic declamping did significant degranulation take place in the oxygenator, and it was temporally associated with further increase in mixed venous plasma lactoferrin. The finding is in accordance with data showing a release of several leukocyte-activating factors only after aortic declamping.Go Go 21,22

On the basis of this study, the precise origin of increased malondialdehyde or degranulation proteins in the IVC cannot be determined. In a canine model, a decrease in body temperature decreases splanchnic and renal perfusion but increases perfusion through the femoral artery.Go 4 Decreased splanchnic perfusion during hypothermia has recently been documented also in human beings.Go 5 In our patients, hypoxanthine concentration decreased and urate concentration increased in the IVC 3 minutes after the onset of perfusion, while hypothermia still was relatively mild. As body temperature decreased, these differences disappeared. This may reflect a shift of perfusion from splanchnic organs containing xanthine oxidase/dehydrogenase to lower extremities in which the enzyme activity is low.Go 18 This mechanism could also account for the changes in myeloperoxidase, lactoferrin, and malondialdehyde concentrations in the IVC in relation to decreasing mixed venous temperature. Endotoxemia caused by intestinal damage has been associated with CPB, and intestinal permeability increases 3 hours after elective coronary artery bypass grafting.Go Go 5,6 Our results suggest that increased splanchnic granulocyte activation and free radical activity during CPB may have pathophysiologic relevance to the intestinal damage associated with cardiac operations.

Footnotes

From Children's Hospital, University of Helsinki,a Helsinki, Finland, Department of Clinical Chemistry, Akademiska Sjukhuset,b Uppsala, Sweden, and Departments I and II of Obstetrics and Gynecology, University of Helsinki,c Helsinki, Finland. Back

References

  1. Menasché P, Piwnica A. Free radicals and myocardial protection: a surgical viewpoint. Ann Thorac Surg 1989;47:939-45.[Abstract]
  2. Chenoweth DE, Cooper SW, Hugli TE, Stewart RW, Blackstone EH, Kirklin JW. Complement activation during cardiopulmonary bypass. N Engl J Med 1981;304:497-503.[Abstract]
  3. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985;312:159-63.[Abstract]
  4. Lazenby WD, Ko W, Zelano JA, et al. Effects of temperature and flow rate on regional blood flow and metabolism during cardiopulmonary bypass. Ann Thorac Surg 1992;53:957-64.[Abstract]
  5. Ohri SK, Somasundaram S, Koak Y, et al. The effect of intestinal hypoperfusion on intestinal absorption and permeability during cardiopulmonary bypass. Gastroenterology 1994;106:318-23.[Medline]
  6. Andersen LW, Baek L, Degn H, Lehd J, Krasnik M, Rasmussen JP. Presence of circulating endotoxins during cardiac operations. J THORAC CARDIOVASC SURG 1987;93:115-9.[Abstract]
  7. Stocchi V, Cucchiarini L, Canestrari F, Piacentini MP, Fornaini G. A very fast ion-pair reversed-phase HPLC method for the separation of the most significant nucleotides and their degradation products in human red blood cells. Anal Biochem 1987;167:181-90.[Medline]
  8. Town MH, Gehm S, Hammer B, Ziegenhorn J. A sensitive colorimetric method for the enzymatic determination of uric acid. J Clin Chem Clin Biochem 1985;23:591.
  9. Olofsson T, Olsson I, Venge P. Myeloperoxidase and lactoferrin of blood neutrophils and plasma in chronic granulocytic leukaemia. Scand J Haematol 1977;18:113-20.[Medline]
  10. Yagi K. Lipid peroxidation: Assay for blood, plasma or serum. In: Packer L, ed. Methods in enzymology. Vol. 105. Oxygen radicals in biological systems. New York: Academic Press, 1984:328-31.
  11. Toivonen HJ, Ahotupa M. Free radical reaction products and antioxidant capacity in arterial plasma during coronary artery bypass grafting. J THORAC CARDIOVASC SURG 1994;108:140-7.[Abstract/Free Full Text]
  12. Royston D, Fleming JS, Desai JB, Westaby S, Taylor KM. Increased production of peroxidation products associated with cardiac operations. J THORAC CARDIOVASC SURG 1986;91:759-66.[Abstract]
  13. Thiringer K, Saugstad OD, Kjellmer I. Plasma hypoxanthine in exteriorized, acutely asphyxiated fetal lambs. Pediatr Res 1980;14:905-9.[Medline]
  14. Kuttila K, Niinikoski J. Peripheral tissue perfusion during coronary artery bypass grafting. Perfusion 1989;4:25-31.[Abstract/Free Full Text]
  15. Thomassen A, Nielsen TT, Bagger JP, Pedersen AK, Henningsen P. Antiischemic and metabolic effects of glutamate during pacing in patients with stable angina pectoris secondary to either coronary artery disease or syndrome X. Am J Cardiol 1991;68:291-5.[Medline]
  16. Robbrecht J, De Buyzere M, Delanghe J, De Scheerder I, Mortier E, Vanderschueren S. Increase of hypoxanthine during cardiac surgery, as measured by an indirect automated enzymatic assay. Clin Chem 1989;35:898-9.[Free Full Text]
  17. Smolenski RT, Lachno DR, Yacoub MH. Adenine nucleotide catabolism in human myocardium during heart and heart-lung transplantation. Eur J Cardiothorac Surg 1992;6:25-30.[Abstract]
  18. Parks DA, Granger DN. Xanthine oxidase: biochemistry, distribution and physiology. Acta Physiol Scand 1986(Suppl);548:87-99.
  19. Eddy LJ, Stewart JR, Jones HP, Engerson TD, McCord JM, Downey JM. Free radical–producing enzyme, xanthine oxidase, is undetectable in human hearts. Am J Physiol 1987;253:H709-11.[Abstract/Free Full Text]
  20. Venge P, Nilsson L, Nyström S-O, Åberg T. Serum and plasma measurements of neutrophil granule proteins during cardiopulmonary bypass: a model to estimate human turnover of lactoferrin and myeloperoxidase. Eur J Haematol 1987;39:339-45.[Medline]
  21. Jansen NJG, van Oeveren W, v.d. Broek L, et al. Inhibition by dexamethasone of the reperfusion phenomena in cardiopulmonary bypass. J THORAC CARDIOVASC SURG 1991;102:515-25.[Abstract]
  22. Jansen NJG, van Oeveren W, Gu YJ, van Vliet H, Eijsman L, Wildevuur CRH. Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass. Ann Thorac Surg 1992;54:744-8.[Abstract]



This article has been cited by other articles:


Home page
PediatricsHome page
C. J. McMahon, D. J. Penny, D. P. Nelson, A. M. Ades, S. Al Maskary, M. Speer, J. Katkin, E. D. McKenzie, C. D. Fraser Jr, MD, and A. C. Chang
Preterm Infants With Congenital Heart Disease and Bronchopulmonary Dysplasia: Postoperative Course and Outcome After Cardiac Surgery
Pediatrics, August 1, 2005; 116(2): 423 - 430.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. B. Andrasi, A. Blazovics, G. Szabo, C. F. Vahl, and S. Hagl
Poly(ADP-ribose) polymerase inhibitor PJ-34 reduces mesenteric vascular injury induced by experimental cardiopulmonary bypass with cardiac arrest
Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2972 - H2978.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
F.-U. Sack, B. Reidenbach, R. Dollner, A. Schledt, M. M. Gebhard, and S. Hagl
Influence of steroids on microvascular perfusion injury of the bowel induced by extracorporeal circulation
Ann. Thorac. Surg., October 1, 2001; 72(4): 1321 - 1326.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
H. A. Hennein
Inflammation After Cardiopulmonary Bypass: Therapy for the Postpump Syndrome
Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2001; 5(3): 236 - 255.
[Abstract] [PDF]


Home page
PerfusionHome page
A. Belboul, D. Roberts, R. Borjesson, and J. Johnsson
Oxygen free radical generation in healthy blood donors and cardiac patients: the protective effect of allopurinol
Perfusion, January 1, 2001; 16(1): 59 - 65.
[Abstract] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Heikki Sairanen
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pesonen, E. J.
Right arrow Articles by Andersson, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pesonen, E. J.
Right arrow Articles by Andersson, S.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS